CASC2 |
Downregulation |
— |
— |
[19] |
GAS5 |
Downregulation |
Tumor suppressor |
Induced PTEN expression via inhibiting miR-103 |
[20] |
MEG3 |
Downregulation |
Tumor suppressor |
Combined directly with PI3K protein and reduced its expression |
[21,22] |
FER1L4 |
Downregulation |
Tumor suppressor |
Enhanced PTEN expression |
[23,24] |
LINC00672 |
Downregulation |
Tumor suppressor |
Served as a locus-restricted cofactor for p53-mediated gene suppression |
[25] |
CCAT2 |
Upregulation |
Oncogene |
Activated the PI3K/AKT pathway by reducing miR-216b expression |
[26] |
BANCR |
Upregulation |
Oncogene |
Activated the MEK/ERK signaling |
[27] |
NEAT1 |
Upregulation |
Oncogene |
Activated the WNT/β-catenin pathway via inhibiting miR-146b and miR-214 expression |
[28] |
MALAT1 |
Upregulation |
Oncogene |
Inhibited miR-200c expression |
[29] |
H19 |
Upregulation |
Oncogene |
Induced EMT via inhibiting let-7 expression |
[30,31,32,33,34,35] |
HOTAIR |
Upregulation |
Oncogene |
Increased NPM1 expression via suppressing miR-646 expression |
[36,37,38,39] |
UCA1 |
Upregulation |
Oncogene |
— |
[40] |
CARLo-5 |
Upregulation |
— |
— |
[41] |
TDRG1 |
Upregulation |
Oncogene |
Directly interacted with VEGF-A protein and upregulated its expression |
[42] |
TUG1 |
Upregulation |
Oncogene |
Increased VEGF-A expression via suppressing miR-34a and miR-299 |
[43] |
PCGEM1 |
Upregulation |
Oncogene |
Activated the STAT3 pathway via reducing miR-129 expression |
[44] |